Literature DB >> 9694070

Antineutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus.

A Bakkaloglu1, R Topaloglu, U Saatçi, S Ozdemir, S Ozen, Y Başsoy, N Beşbaş.   

Abstract

We aimed to evaluate the presence of peripheral antineutrophil cytoplasmic antibodies (p-ANCA) and cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA) in children with SLE and to correlate its association of laboratory findings. Twenty-one children with SLE were studied. Serum samples in patients were tested by indirect immunofluorescence (IIF) slide kit (INOVA) for c-ANCA and p-ANCA and by ELISA for myeloperoxidase (MPO-ANCA) and proteinase 3 (PR3-ANCA). All the patients but two were quiescent for lupus at the time of sampling. Sixteen of 21 patients showed positive IIF staining whereas only 5 had MPO-ANCA and 2 of nine PR3-ANCA. The data suggests that SLE may be associated p-ANCA directed against additional target antigens rather than MPO and may be implicated in the pathogenesis of SLE or may be only non-specific antibodies developed in lupus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694070     DOI: 10.1007/bf01451065

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

1.  Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.

Authors:  S Küster; S Apenberg; K Andrassy; E Ritz
Journal:  Contrib Nephrol       Date:  1992       Impact factor: 1.580

Review 2.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

3.  Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.

Authors:  P E Spronk; H Bootsma; G Horst; M G Huitema; P C Limburg; J W Tervaert; C G Kallenberg
Journal:  Br J Rheumatol       Date:  1996-07

4.  Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.

Authors:  L Nässberger; A G Sjöholm; H Jonsson; G Sturfelt; A Akesson
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis.

Authors:  G Cambridge; H Wallace; R M Bernstein; B Leaker
Journal:  Br J Rheumatol       Date:  1994-02

6.  Antilactoferrin antibody in systemic lupus erythematosus.

Authors:  S S Lee; J W Lawton; C E Chan; C S Li; T H Kwan; K F Chau
Journal:  Br J Rheumatol       Date:  1992-10

Review 7.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

8.  Anti-neutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus.

Authors:  S N Wong; V Shah; M J Dillon
Journal:  Eur J Pediatr       Date:  1995-01       Impact factor: 3.183

9.  Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.

Authors:  R Pauzner; M Urowitz; D Gladman; J Gough
Journal:  J Rheumatol       Date:  1994-09       Impact factor: 4.666

10.  Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance.

Authors:  A Schnabel; E Csernok; D A Isenberg; C Mrowka; W L Gross
Journal:  Arthritis Rheum       Date:  1995-05
  10 in total
  3 in total

Review 1.  Neutrophils in the pathogenesis and manifestations of SLE.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

2.  Autoimmune rheumatic disease IgG has differential effects upon neutrophil integrin activation that is modulated by the endothelium.

Authors:  Akif A Khawaja; Charis Pericleous; Vera M Ripoll; Joanna C Porter; Ian P Giles
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

3.  The Impact of Serum Anti-neutrophil Cytoplasmic Antibody on Clinical Characteristics and Outcomes in Pediatric-Onset Systemic Lupus Erythematosus Patients.

Authors:  Chun-Chun Gau; Min-Hua Tseng; Chao-Yi Wu; Huang-Yu Yang; Jing-Long Huang
Journal:  Front Med (Lausanne)       Date:  2021-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.